Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
27-May-2026 | 378.45 | 380.75 | 374.2 | 377.35 | 3,766 | 7,61,69,538.45 | 94,362 |
29-May-2026 | 379.95 | 381.4 | 367.1 | 369.25 | 3,511 | 5,96,11,757.55 | 92,597 |
01-Jun-2026 | 369.25 | 371 | 357.5 | 359.5 | 4,925 | 9,67,98,741.55 | 1,43,050 |
02-Jun-2026 | 359 | 365.9 | 354.1 | 363.95 | 3,429 | 4,47,89,656.6 | 51,343 |
03-Jun-2026 | 364.2 | 364.6 | 352.7 | 356.5 | 4,737 | 5,82,71,721.65 | 74,527 |
04-Jun-2026 | 357.4 | 359.9 | 352 | 353.65 | 2,649 | 3,87,13,179.2 | 61,778 |
05-Jun-2026 | 353.65 | 378.65 | 351 | 369.1 | 6,503 | 12,25,41,358.5 | 1,13,166 |
08-Jun-2026 | 363.25 | 375.95 | 363.25 | 368.8 | 5,141 | 6,80,71,996.55 | 83,650 |
09-Jun-2026 | 367.6 | 389.4 | 367.6 | 377.45 | 8,643 | 12,76,02,577.3 | 1,25,319 |
10-Jun-2026 | 377.9 | 399.9 | 376.25 | 381.55 | 11,035 | 18,30,90,143.35 | 1,66,332 |
11-Jun-2026 | 380.35 | 386.15 | 376.3 | 379.2 | 3,495 | 4,88,25,509.5 | 55,052 |
12-Jun-2026 | 383 | 389.7 | 376.55 | 383.45 | 3,504 | 4,90,88,809.45 | 44,139 |
15-Jun-2026 | 387 | 393.1 | 376.8 | 378 | 2,579 | 4,08,38,051.55 | 58,952 |
16-Jun-2026 | 378.1 | 382.2 | 375.1 | 376.4 | 1,860 | 2,29,48,311.75 | 31,960 |
17-Jun-2026 | 374 | 381.55 | 372.9 | 375.95 | 3,126 | 4,26,93,654 | 55,260 |
18-Jun-2026 | 379.85 | 381.7 | 370.35 | 374.15 | 2,160 | 3,39,25,666.3 | 43,514 |
19-Jun-2026 | 374.4 | 386 | 373.15 | 378.6 | 2,916 | 3,94,24,002.6 | 45,573 |
22-Jun-2026 | 378.3 | 381.2 | 372.45 | 374.5 | 1,823 | 3,08,99,772.15 | 52,815 |
23-Jun-2026 | 374.5 | 388.6 | 374.5 | 380.3 | 3,845 | 6,98,03,342.45 | 65,050 |
24-Jun-2026 | 380.35 | 386.95 | 377.05 | 378.5 | 1,594 | 2,60,07,398.65 | 30,061 |
25-Jun-2026 | 377.15 | 381.8 | 374 | 376.55 | 1,333 | 2,62,27,261.15 | 36,540 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
